Hemothorax as the Initial Manifestation of Positive Pulmonary Pleomorphic Carcinoma: A Case Report.
증례보고
1/5 보강
Pulmonary pleomorphic carcinoma (PPC) is a rare subtype of lung cancer that is characterised by rapid progression and poor prognosis.
APA
Ikeda T, Matsumoto H, et al. (2026). Hemothorax as the Initial Manifestation of Positive Pulmonary Pleomorphic Carcinoma: A Case Report.. Respirology case reports, 14(1), e70454. https://doi.org/10.1002/rcr2.70454
MLA
Ikeda T, et al.. "Hemothorax as the Initial Manifestation of Positive Pulmonary Pleomorphic Carcinoma: A Case Report.." Respirology case reports, vol. 14, no. 1, 2026, pp. e70454.
PMID
41503246 ↗
Abstract 한글 요약
Pulmonary pleomorphic carcinoma (PPC) is a rare subtype of lung cancer that is characterised by rapid progression and poor prognosis. Hemothorax as the initial clinical presentation of PPC is exceptionally rare and, to the best of our knowledge, has not been previously reported. Here, we report a rare case of a KRAS G12D-mutated PPC penetrating the visceral pleura, leading to rapid tumour growth and uncontrolled hemothorax. In addition to the high proliferative and invasive potential of the tumour, the oncological properties associated with the KRAS G12D mutation likely precipitated both the abrupt onset and recurrence of massive hemothorax. Early recognition, complete macroscopic resection to achieve definitive haemostasis, and prompt initiation of postoperative therapy are essential to improve clinical outcomes.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (3)
- Lung cancer initially presenting with diffuse alveolar damage and brain infarction: An autopsy case report.
- Feasibility of Minimally Invasive Surgery for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy: A Four-arm Comparative Study.
- [Pulmonary Herniation Requiring Reconstructive Surgery Caused by Minimally Invasive Cardiac Surgery:Report of a Case].
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Ferritin-based nanocarrier delivery of KRAS G12D inhibitor in pancreatic adenocarcinoma cells and patient-derived organoids: A novel approach for treatment.
- Five-year outcomes of pembrolizumab versus chemotherapy in Chinese patients with non-small-cell lung cancer and programmed cell death ligand 1 tumor proportion score ≥1%: KEYNOTE-042 China study.
- Next-Generation Sequencing-Based Detection of G12D Variants in Colorectal Cancer: A Retrospective Cohort Study.
- Amplification-free CRISPR/Cas13a-based electrochemical biosensor for the detection of circulating tumor RNA using RNA-3Ag⁺ probes on Au porous-lattice nanoelectrode.
- Esophageal Perforation With Right-Sided Hemothorax in a Patient With Suspected Variceal Bleeding: A Diagnostic Challenge.
- A comprehensive analysis of the correlation between plasma cytokines/chemokines and tumor immune microenvironment signature influences the response of checkpoint inhibitors in advanced non-small-cell lung cancer.